How many SC 13D/A filings has Cartesian Therapeutics, Inc. filed?

Cartesian Therapeutics, Inc. (RNAC) has 8 SC 13D/A (SC 13D/A) filings on record, spanning Mar 2024 to Nov 2024.

What is a SC 13D/A filing?

A SC 13D/A is an SEC filing known as "SC 13D/A." It is filed with the SEC as a SC 13D/A.

Where can I read Cartesian Therapeutics, Inc. SC 13D/A filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Cartesian Therapeutics, Inc. SC 13D/A filings, including risk assessment, sentiment analysis, and key financial figures.

Cartesian Therapeutics, Inc. (RNAC) — SC 13D/A Filings

All SC 13D/A filings from Cartesian Therapeutics, Inc.. Browse 8 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (8)

Springer Amends Cartesian Therapeutics Stake — Nov 18, 2024 Risk: medium
Timothy A. Springer, through TAS Partners LLC, has amended their Schedule 13D filing for Cartesian Therapeutics, Inc. on November 18, 2024. The filing indicates
Cartesian Therapeutics Ownership Update — Oct 15, 2024 Risk: medium
On October 11, 2024, Murat Kalayoglu, Elizabeth Hoge, and the Seven One Eight Three Four Irrevocable Trust filed an amendment (No. 2) to their Schedule 13D for
Springer Amends Stake in Cartesian Therapeutics — Oct 4, 2024 Risk: medium
On October 4, 2024, Timothy A. Springer filed Amendment No. 16 to Schedule 13D for Cartesian Therapeutics, Inc. This filing indicates a change in beneficial own
Springer Amends 13D Filing for Cartesian Therapeutics — Sep 27, 2024 Risk: medium
Timothy A. Springer filed Amendment No. 15 to Schedule 13D on September 25, 2024, regarding Cartesian Therapeutics, Inc. The filing indicates a change in benefi
Springer Amends Cartesian Therapeutics Stake Filing — Jul 5, 2024 Risk: medium
Timothy A. Springer, through TAS Partners LLC, has amended their Schedule 13D filing regarding Cartesian Therapeutics, Inc. as of July 2, 2024. The filing indic
Springer Amends 13D Filing for Cartesian Therapeutics — Apr 12, 2024 Risk: medium
Timothy A. Springer filed an amendment (No. 13) to Schedule 13D on April 12, 2024, regarding Cartesian Therapeutics, Inc. The filing indicates a change in benef
Singer Amends Cartesian Therapeutics Stake Filing — Apr 10, 2024 Risk: medium
On April 8, 2024, Michael Singer, through various trusts and entities including the 2019 Irrevocable Trust and Singer Asezadeh Family Holding Trust, filed an am
Springer Amends Stake in Cartesian Therapeutics — Mar 28, 2024 Risk: medium
Timothy A. Springer filed an amendment (No. 12) to Schedule 13D on March 28, 2024, regarding Cartesian Therapeutics, Inc. The filing indicates a change in benef

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX